N-Q 1 a18-40402_3nq.htm N-Q

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM N-Q

 

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED
MANAGEMENT INVESTMENT COMPANY

 

Investment Company Act file number

811-03692

 

Morgan Stanley Variable Investment Series

(Exact name of registrant as specified in charter)

 

522 Fifth Avenue, New York, New York

 

10036

(Address of principal executive offices)

 

(Zip code)

 

John H. Gernon
522 Fifth Avenue, New York, New York 10036

(Name and address of agent for service)

 

Registrant’s telephone number, including area code:

212-296-0289

 

 

Date of fiscal year end:

December 31,

 

 

Date of reporting period:

September 30, 2018

 

 


 

Item 1.  Schedule of Investments.

 

The Registrant’s schedule of investments as of the close of the reporting period prepared pursuant to Rule 12-12 of Regulation S-X is as follows:

 


 

Morgan Stanley Variable Investment Series - Limited Duration Portfolio

Portfolio of Investments · September 30, 2018 (unaudited)

 

PRINCIPAL
AMOUNT
(000)

 

 

 

COUPON
RATE

 

MATURITY
DATE

 

VALUE

 

 

 

Corporate Bonds (64.3%)

 

 

 

 

 

 

 

 

 

Basic Materials (0.6%)

 

 

 

 

 

 

 

$

125

 

EI du Pont de Nemours & Co.

 

2.20

%

05/01/20

 

$

123,387

 

 

 

 

 

 

 

 

 

 

 

 

 

Communications (7.3%)

 

 

 

 

 

 

 

400

 

AT&T, Inc.

 

2.45

 

06/30/20

 

394,821

 

200

 

CBS Corp.

 

2.30

 

08/15/19

 

198,982

 

150

 

Deutsche Telekom International Finance BV (Germany) (a)

 

2.225

 

01/17/20

 

148,249

 

125

 

Discovery Communications LLC

 

2.20

 

09/20/19

 

124,051

 

175

 

Discovery Communications LLC (a)

 

2.75

 

11/15/19

 

173,956

 

225

 

Orange SA (France)

 

2.75

 

02/06/19

 

225,080

 

150

 

Sprint Spectrum Co., LLC/Sprint Spectrum Co., II LLC/Sprint Spectrum Co., III LLC (a)

 

3.36

 

09/20/21

 

149,813

 

230

 

Verizon Communications, Inc.

 

2.946

 

03/15/22

 

226,532

 

 

 

 

 

 

 

 

 

1,641,484

 

 

 

Consumer, Cyclical (5.7%)

 

 

 

 

 

 

 

90

 

Alimentation Couche-Tard, Inc. (Canada) (a)

 

2.35

 

12/13/19

 

89,155

 

175

 

CVS Health Corp.

 

2.125

 

06/01/21

 

169,023

 

100

 

Delta Air Lines, Inc.

 

2.875

 

03/13/20

 

99,226

 

70

 

DR Horton, Inc.

 

2.55

 

12/01/20

 

68,603

 

200

 

Ford Motor Credit Co., LLC

 

2.681

 

01/09/20

 

197,980

 

125

 

General Motors Co., 3 Month USD LIBOR + 0.80%

 

3.143

(b)

08/07/20

 

125,453

 

50

 

Hyundai Capital America (a)

 

2.55

 

04/03/20

 

49,177

 

100

 

Hyundai Capital America (Korea, Republic of) (a)

 

2.60

 

03/19/20

 

98,583

 

175

 

Southwest Airlines Co.

 

2.75

 

11/06/19

 

174,344

 

200

 

Volkswagen Group of America Finance LLC (Germany) (a)

 

2.40

 

05/22/20

 

196,678

 

 

 

 

 

 

 

 

 

1,268,222

 

 

 

Consumer, Non-Cyclical (14.3%)

 

 

 

 

 

 

 

175

 

AbbVie, Inc.

 

2.50

 

05/14/20

 

173,107

 

280

 

Allergan Funding SCS

 

3.00

 

03/12/20

 

279,751

 

200

 

Anheuser-Busch InBev Finance, Inc. (Belgium)

 

2.65

 

02/01/21

 

197,206

 

150

 

BAT International Finance PLC (United Kingdom) (a)

 

2.75

 

06/15/20

 

148,497

 

53

 

Baxalta, Inc.

 

2.875

 

06/23/20

 

52,583

 

200

 

Bayer US Finance LLC (a)

 

2.375

 

10/08/19

 

198,723

 

100

 

Becton Dickinson and Co.

 

2.675

 

12/15/19

 

99,468

 

175

 

Biogen, Inc.

 

2.90

 

09/15/20

 

174,175

 

50

 

Cardinal Health, Inc.

 

1.948

 

06/14/19

 

49,728

 

175

 

Celgene Corp.

 

2.875

 

08/15/20

 

173,929

 

200

 

Danone SA (France) (a)

 

1.691

 

10/30/19

 

197,107

 

175

 

EMD Finance LLC (Germany) (a)

 

2.40

 

03/19/20

 

172,715

 

175

 

Gilead Sciences, Inc.

 

2.55

 

09/01/20

 

173,289

 

75

 

JM Smucker Co. (The)

 

2.50

 

03/15/20

 

74,309

 

150

 

Kroger Co. (The)

 

2.30

 

01/15/19

 

149,825

 

50

 

Mead Johnson Nutrition Co.

 

3.00

 

11/15/20

 

49,840

 

175

 

Medtronic, Inc.

 

2.50

 

03/15/20

 

173,871

 

150

 

Molson Coors Brewing Co.

 

1.45

 

07/15/19

 

148,268

 

125

 

Synchrony Financial

 

3.00

 

08/15/19

 

124,772

 

250

 

Tyson Foods, Inc.

 

2.65

 

08/15/19

 

249,611

 

150

 

UnitedHealth Group, Inc.

 

2.70

 

07/15/20

 

149,096

 

 

 

 

 

 

 

 

 

3,209,870

 

 

 

Energy (2.1%)

 

 

 

 

 

 

 

100

 

BP Capital Markets PLC (United Kingdom)

 

2.315

 

02/13/20

 

99,126

 

125

 

Enterprise Products Operating LLC

 

2.55

 

10/15/19

 

124,535

 

200

 

Kinder Morgan, Inc.

 

3.05

 

12/01/19

 

199,836

 

 


 

60

 

Schlumberger Finance Canada Ltd. (Canada) (a)

 

2.20

 

11/20/20

 

58,604

 

 

 

 

 

 

 

 

 

482,101

 

 

 

Finance (24.4%)

 

 

 

 

 

 

 

150

 

Air Lease Corp.

 

2.125

 

01/15/20

 

147,684

 

280

 

Bank of America Corp., MTN

 

2.625

 

10/19/20

 

276,699

 

260

 

BNZ International Funding Ltd. (New Zealand) (a)

 

2.35

 

03/04/19

 

259,611

 

275

 

BPCE SA, MTN (France)

 

2.25

 

01/27/20

 

271,539

 

130

 

Capital One Financial Corp.

 

2.40

 

10/30/20

 

127,343

 

200

 

Danske Bank A/S (Denmark) (a)

 

1.65

 

09/06/19

 

197,117

 

225

 

DBS Group Holdings Ltd. (Singapore) (a)

 

2.246

 

07/16/19

 

223,922

 

100

 

Deutsche Bank AG (Germany)

 

2.70

 

07/13/20

 

97,999

 

200

 

DNB Bank ASA (Norway) (a)

 

2.125

 

10/02/20

 

194,839

 

175

 

ERP Operating LP

 

2.375

 

07/01/19

 

174,325

 

175

 

Goldman Sachs Group, Inc. (The)

 

2.35

 

11/15/21

 

168,968

 

125

 

Goldman Sachs Group, Inc. (The)

 

2.625

 

04/25/21

 

122,504

 

220

 

HSBC USA, Inc.

 

2.25

 

06/23/19

 

219,288

 

100

 

Jackson National Life Global Funding (a)

 

1.875

 

10/15/18

 

99,978

 

100

 

Jackson National Life Global Funding (a)

 

2.20

 

01/30/20

 

98,812

 

50

 

JPMorgan Chase & Co., MTN

 

2.295

 

08/15/21

 

48,635

 

250

 

JPMorgan Chase Bank NA

 

2.604

 

02/01/21

 

248,174

 

200

 

LeasePlan Corp. N.V. (Netherlands) (a)

 

2.875

 

01/22/19

 

199,862

 

200

 

Lloyds Banking Group PLC (United Kingdom)

 

3.10

 

07/06/21

 

197,237

 

201

 

Macquarie Bank Ltd. (Australia) (a)

 

2.60

 

06/24/19

 

200,520

 

175

 

Metropolitan Life Global Funding I (a)(c)

 

2.00

 

04/14/20

 

172,076

 

150

 

Metropolitan Life Global Funding I (a)(c)

 

2.05

 

06/12/20

 

147,113

 

250

 

National Bank of Canada (Canada)

 

2.15

 

06/12/20

 

245,671

 

250

 

Principal Life Global Funding II (a)

 

2.15

 

01/10/20

 

247,389

 

150

 

Protective Life Global Funding (a)

 

1.722

 

04/15/19

 

149,204

 

150

 

Protective Life Global Funding (a)

 

2.70

 

11/25/20

 

147,931

 

250

 

Skandinaviska Enskilda Banken AB (Sweden)

 

2.30

 

03/11/20

 

246,927

 

90

 

Suncorp-Metway Ltd. (Australia) (a)

 

2.375

 

11/09/20

 

87,749

 

200

 

WEA Finance LLC/Westfield UK & Europe Finance PLC (a)

 

2.70

 

09/17/19

 

199,522

 

250

 

Wells Fargo & Co.

 

2.60

 

07/22/20

 

247,585

 

 

 

 

 

 

 

 

 

5,466,223

 

 

 

Industrials (3.1%)

 

 

 

 

 

 

 

50

 

Harris Corp.

 

2.70

 

04/27/20

 

49,524

 

75

 

Lockheed Martin Corp.

 

2.50

 

11/23/20

 

73,994

 

125

 

Northrop Grumman Corp.

 

2.55

 

10/15/22

 

120,628

 

150

 

Rockwell Collins, Inc.

 

1.95

 

07/15/19

 

149,018

 

50

 

Ryder System, Inc., MTN

 

2.65

 

03/02/20

 

49,587

 

250

 

Siemens Financieringsmaatschappij N.V. (Germany) (a)

 

2.15

 

05/27/20

 

246,826

 

 

 

 

 

 

 

 

 

689,577

 

 

 

Technology (1.5%)

 

 

 

 

 

 

 

125

 

Broadcom Corp./Broadcom Cayman Finance Ltd.

 

2.20

 

01/15/21

 

121,182

 

100

 

Hewlett Packard Enterprise Co. (a)

 

2.10

 

10/04/19

 

99,050

 

125

 

Lam Research Corp.

 

2.80

 

06/15/21

 

122,934

 

 

 

 

 

 

 

 

 

343,166

 

 

 

Utilities (5.3%)

 

 

 

 

 

 

 

50

 

Berkshire Hathaway Energy Co.

 

2.375

 

01/15/21

 

49,209

 

275

 

Dominion Energy Gas Holdings LLC

 

2.50

 

12/15/19

 

273,000

 

75

 

DTE Energy Co.

 

1.50

 

10/01/19

 

73,832

 

100

 

Duke Energy Corp.

 

1.80

 

09/01/21

 

95,710

 

70

 

Eversource Energy

 

2.50

 

03/15/21

 

68,804

 

200

 

Origin Energy Finance Ltd. (Australia) (a)

 

3.50

 

10/09/18

 

199,997

 

175

 

Sempra Energy

 

2.40

 

03/15/20

 

172,686

 

250

 

Southern Co. (The)

 

2.15

 

09/01/19

 

247,976

 

 

 

 

 

 

 

 

 

1,181,214

 

 

 

Total Corporate Bonds (Cost $14,537,284)

 

 

 

 

 

14,405,244

 

 


 

 

 

Asset-Backed Securities (7.3%)

 

 

 

 

 

 

 

74

 

Bayview Opportunity Master Fund IVb Trust (a)

 

3.50

(b)

01/28/55

 

73,980

 

100

 

Finance of America Structured Securities Trust (a)

 

3.624

(b)

11/25/27

 

99,017

 

 

 

Nationstar HECM Loan Trust

 

 

 

 

 

 

 

100

 

(a)

 

2.815

(b)

09/25/27

 

99,531

 

100

 

(a)

 

2.942

 

05/25/27

 

99,267

 

81

 

New Residential Mortgage Loan Trust (a)

 

4.00

(b)

08/27/57

 

80,977

 

87

 

North Carolina State Education Assistance Authority, 3 Month USD LIBOR + 0.80%

 

3.135

(b)

07/25/25

 

87,406

 

 

 

NRZ Excess Spread-Collateralized Notes

 

 

 

 

 

 

 

83

 

(a)

 

4.374

 

01/25/23

 

82,725

 

86

 

(a)

 

4.593

 

02/25/23

 

84,978

 

100

 

Ocwen Master Advance Receivables Trust (a)

 

2.722

 

08/16/49

 

99,500

 

26

 

Option One Mortgage Loan Trust Asset-Backed Certificates, 1 Month USD LIBOR + 0.50%

 

2.665

(b)

08/20/30

 

25,315

 

16

 

Panhandle-Plains Higher Education Authority, Inc., 3 Month USD LIBOR + 0.95%

 

3.287

(b)

07/01/24

 

15,700

 

 

 

PFS Financing Corp.

 

 

 

 

 

 

 

100

 

(a)

 

2.57

 

07/15/22

 

98,211

 

100

 

(a)

 

2.74

 

10/17/22

 

97,829

 

100

 

(a)

 

2.89

 

02/15/23

 

98,925

 

100

 

(a)

 

3.19

 

04/17/23

 

99,407

 

92

 

PRPM LLC (a)

 

3.75

(b)

04/25/23

 

91,940

 

47

 

Skopos Auto Receivables Trust (a)

 

5.43

 

12/15/23

 

47,457

 

100

 

SPS Servicer Advance Receivables Trust Advance Receivables Backed Notes (a)

 

2.53

 

11/16/48

 

100,073

 

63

 

TLF National Tax Lien Trust (a)

 

3.09

 

12/15/29

 

63,114

 

99

 

Vantage Data Centers Issuer LLC (a)

 

4.072

 

02/16/43

 

99,571

 

 

 

Total Asset-Backed Securities (Cost $1,656,247)

 

 

 

 

 

1,644,923

 

 

 

 

 

 

 

 

 

 

 

 

 

Mortgages - Other (3.7%)

 

 

 

 

 

 

 

49

 

CHL Mortgage Pass-Through Trust

 

5.50

 

05/25/34

 

49,720

 

197

 

Federal Home Loan Mortgage Corporation, 1 Month USD LIBOR + 0.55%

 

2.766

(b)

04/25/30

 

197,145

 

 

 

Federal National Mortgage Association

 

 

 

 

 

 

 

70

 

1 Month USD LIBOR + 1.30%

 

3.516

(b)

05/25/29–07/25/29

 

70,805

 

5

 

1 Month USD LIBOR + 2.20%

 

4.416

(b)

10/25/28

 

5,498

 

77

 

Galton Funding Mortgage Trust (a)

 

3.50

(b)

11/25/57

 

77,261

 

47

 

JP Morgan Mortgage Trust

 

4.481

(b)

07/25/35

 

47,351

 

80

 

Merrill Lynch Mortgage Investors Trust

 

4.05

(b)

12/25/34

 

80,685

 

205

 

New Residential Mortgage Loan Trust (a) 

 

3.75

(b)

11/26/35- 08/25/55

 

205,834

 

87

 

Sequoia Mortgage Trust, 1 Month USD LIBOR + 0.62%

 

2.785

(b)

08/20/34

 

86,662

 

 

 

Total Mortgages - Other (Cost $823,610)

 

 

 

 

 

820,961

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury Security (2.2%)

 

 

 

 

 

 

 

525

 

U.S. Treasury Note (Cost $493,822)

 

1.375

 

06/30/23

 

488,773

 

 

 

 

 

 

 

 

 

 

 

 

 

Collateralized Mortgage Obligations - Agency Collateral Series (0.5%)

 

 

 

 

 

 

 

83

 

Federal Home Loan Mortgage Corporation, REMIC

 

7.50

 

09/15/29

 

92,098

 

215

 

Government National Mortgage Association, IO PAC, 6.15% - 1 Month USD LIBOR

 

3.985

(b)

10/20/41

 

16,461

 

 

 

Total Collateralized Mortgage Obligations - Agency Collateral Series (Cost $96,579)

 

 

 

 

 

108,559

 

 

 

 

 

 

 

 

 

 

 

 

 

Agency Fixed Rate Mortgages (0.3%)

 

 

 

 

 

 

 

 

 

Federal National Mortgage Association,

 

 

 

 

 

 

 

 

 

Conventional Pools:

 

 

 

 

 

 

 

44

 

 

 

6.50

 

01/01/32

 

48,239

 

19

 

 

 

7.00

 

12/01/31–06/01/32

 

19,376

 

 

 

Total Agency Fixed Rate Mortgages (Cost $65,932)

 

 

 

 

 

67,615

 

 


 

 

 

Short-Term Investments (17.4%)

 

 

 

 

 

 

 

 

 

U.S. Treasury Security (0.2%)

 

 

 

 

 

 

 

51

 

U.S. Treasury Bill (d)(e) (Cost $50,913)

 

2.022

 

11/01/18

 

50,913

 

 

NUMBER OF
SHARES
(000)

 

 

 

 

 

 

 

 

 

 

 

Investment Company (17.2%)

 

 

 

 

 

 

 

3,866

 

Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class (f) (Cost $3,866,334)

 

 

 

 

 

3,866,334

 

 

 

Total Short-Term Investments (Cost $3,917,247)

 

 

 

 

 

3,917,247

 

 

 

 

 

 

 

 

 

 

 

 

 

Total Investments (Cost $21,590,721) (g)(h)(i)

 

 

 

95.7

%

21,453,322

 

 

 

Other Assets in Excess of Liabilities

 

 

 

4.3

 

970,652

 

 

 

Net Assets

 

 

 

100.0

%

$

22,423,974

 

 


IO

 

Interest Only.

LIBOR

 

London Interbank Offered Rate.

MTN

 

Medium Term Note.

PAC

 

Planned Amortization Class.

REMIC

 

Real Estate Mortgage Investment Conduit.

(a)

 

144A security — Certain conditions for public sale may exist. Unless otherwise noted, these securities are deemed to be liquid.

(b)

 

Floating or Variable rate securities: The rates disclosed are as of September 30, 2018. For securities based on a published reference rate and spread, the reference rate and spread are indicated in the description in the Portfolio of Investments. Certain variable rate securities may not be based on a published reference rate and spread but are determined by the issuer or agent and are based on current market conditions. These securities do not indicate a reference rate and spread in their description in the Portfolio of Investments.

(c)

 

For the nine months ended September 30, 2018, there were no transactions in Metropolitan Life Global Funding I, Corporate bond, and its affiliated broker-dealers, which may be deemed affiliates of the Adviser/Administrator and Distributor.

(d)

 

Rate shown is the yield to maturity at September 30, 2018.

(e)

 

All or a portion of the security was pledged to cover margin requirements for futures contracts.

(f)

 

The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio - (the “Liquidity Funds”), an open-end management investment company managed by the Adviser. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2018, advisory fees paid were reduced by $795 relating to the Fund’s investment in the Liquidity Funds.

(g)

 

Securities are available for collateral in connection with open futures contracts.

(h)

 

The Fund is permitted to purchase and sell securities (“cross-trade”) from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the “Rule”). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2018, the Fund did not engage in any cross-trade transactions.

(i)

 

At September 30, 2018, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $23,261 and the aggregate gross unrealized depreciation is $205,700, resulting in net unrealized depreciation of $182,439.

 


 

Futures Contracts:
The Fund had the following futures contracts open at September 30, 2018:

 

 

 

Number
of
Contracts

 

Expiration
Date

 

Notional Amount
(000)

 

Value

 

Unrealized
Appreciation
(Depreciation)

 

Long:

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury 2 yr. Note

 

34

 

Dec-18

 

6,800

 

$

7,164,969

 

$

(12,672

)

U.S. Treasury 5 yr. Note

 

38

 

Dec-18

 

3,800

 

4,274,109

 

(32,446

)

Short:

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury 10 yr. Ultra Long Bond

 

1

 

Dec-18

 

(100

)

(126,000

)

78

 

 

 

 

 

 

 

 

 

 

 

$

(45,040

)

 


 

Morgan Stanley Variable Investment Series - Income Plus Portfolio

Portfolio of Investments · September 30, 2018 (unaudited)

 

PRINCIPAL
AMOUNT
(000)

 

 

 

COUPON
RATE

 

MATURITY
DATE

 

VALUE

 

 

 

Corporate Bonds (96.4%)

 

 

 

 

 

 

 

 

 

Basic Materials (4.6%)

 

 

 

 

 

 

 

$

190

 

Eldorado Gold Corp. (Canada) (a)

 

6.125

%

12/15/20

 

$

180,975

 

475

 

Glencore Funding LLC (Switzerland) (a)

 

3.875

 

10/27/27

 

441,557

 

175

 

Goldcorp, Inc. (Canada)

 

5.45

 

06/09/44

 

182,210

 

450

 

International Paper Co.

 

3.00

 

02/15/27

 

413,904

 

100

 

LyondellBasell Industries N.V.

 

4.625

 

02/26/55

 

90,245

 

500

 

Newcastle Coal Infrastructure Group Pty Ltd. (Australia) (a)

 

4.40

 

09/29/27

 

454,487

 

470

 

NOVA Chemicals Corp. (Canada) (a)

 

5.25

 

08/01/23

 

469,119

 

150

 

Nucor Corp.

 

3.95

 

05/01/28

 

150,066

 

200

 

POSCO (Korea, Republic of) (a)

 

4.00

 

08/01/23

 

200,000

 

315

 

Southern Copper Corp. (Mexico)

 

7.50

 

07/27/35

 

391,387

 

425

 

Syngenta Finance N.V. (China) (a)

 

4.892

 

04/24/25

 

417,752

 

220

 

Vale Overseas Ltd. (Brazil)

 

6.875

 

11/21/36

 

256,564

 

175

 

Westlake Chemical Corp.

 

4.375

 

11/15/47

 

156,067

 

 

 

 

 

 

 

 

 

3,804,333

 

 

 

Communications (11.4%)

 

 

 

 

 

 

 

225

 

21st Century Fox America, Inc.

 

4.75

 

09/15/44

 

241,864

 

300

 

Amazon.com, Inc.

 

4.25

 

08/22/57

 

301,285

 

200

 

AT&T, Inc.

 

4.25

 

03/01/27

 

197,762

 

151

 

AT&T, Inc.

 

4.50

 

03/09/48

 

132,265

 

350

 

AT&T, Inc. (a)

 

4.90

 

08/15/37

 

336,895

 

500

 

AT&T, Inc. (a)

 

5.15

 

02/15/50

 

475,997

 

220

 

Baidu, Inc. (China)

 

2.875

 

07/06/22

 

211,866

 

150

 

Booking Holdings, Inc.

 

0.90

 

09/15/21

 

178,342

 

425

 

Charter Communications Operating LLC/Charter Communications Operating Capital

 

4.20

 

03/15/28

 

407,380

 

400

 

Charter Communications Operating LLC/Charter Communications Operating Capital

 

6.484

 

10/23/45

 

431,402

 

725

 

Comcast Corp.

 

3.15

 

02/15/28

 

673,089

 

350

 

Comcast Corp.

 

3.55

 

05/01/28

 

335,493

 

225

 

CSC Holdings LLC (a)

 

5.50

 

04/15/27

 

218,812

 

175

 

Ctrip.com International Ltd. (China)

 

1.25

 

09/15/22

 

171,605

 

275

 

Finisar Corp.

 

0.50

 

12/15/36

 

252,599

 

900

 

Ooredoo International Finance Ltd. (Qatar) (a)

 

3.25

 

02/21/23

 

868,500

 

619

 

Sprint Spectrum Co., LLC/Sprint Spectrum Co., II LLC/Sprint Spectrum Co., III LLC (a)

 

3.36

 

03/20/23

 

617,977

 

200

 

Sprint Spectrum Co., LLC/Sprint Spectrum Co., II LLC/Sprint Spectrum Co., III LLC (a)

 

4.738

 

09/20/29

 

200,410

 

225

 

Symantec Corp. (a)

 

5.00

 

04/15/25

 

223,188

 

175

 

Telefonica Emisiones SAU (Spain)

 

4.103

 

03/08/27

 

168,522

 

330

 

Telefonica Europe BV (Spain)

 

8.25

 

09/15/30

 

423,142

 

200

 

Telenor East Holding II AS, Series VIP (Norway)

 

0.25

 

09/20/19

 

195,938

 

375

 

Tencent Holdings Ltd. (China) (a)

 

3.595

 

01/19/28

 

355,356

 

75

 

Verizon Communications, Inc.

 

4.125

 

03/16/27

 

75,475

 

375

 

Verizon Communications, Inc.

 

4.272

 

01/15/36

 

358,444

 

540

 

Verizon Communications, Inc.

 

4.672

 

03/15/55

 

509,808

 

125

 

Viacom, Inc.

 

5.85

 

09/01/43

 

132,686

 

200

 

Vodafone Group PLC (United Kingdom)

 

4.375

 

02/19/43

 

180,503

 

400

 

Warner Media LLC

 

3.80

 

02/15/27

 

383,300

 

225

 

Zillow Group, Inc.

 

2.00

 

12/01/21

 

244,406

 

 

 

 

 

 

 

 

 

9,504,311

 

 

 

Consumer, Cyclical (7.7%)

 

 

 

 

 

 

 

275

 

Alimentation Couche-Tard, Inc. (Canada) (a)

 

3.55

 

07/26/27

 

259,161

 

319

 

American Airlines Pass-Through Trust

 

4.00

 

01/15/27

 

318,256

 

517

 

British Airways Pass-Through Trust (United Kingdom) (a)

 

4.625

 

12/20/25

 

529,487

 

 


 

125

 

CVS Health Corp.

 

4.30

 

03/25/28

 

124,259

 

525

 

CVS Health Corp.

 

4.78

 

03/25/38

 

524,130

 

325

 

Darden Restaurants, Inc.

 

3.85

 

05/01/27

 

315,341

 

25

 

Darden Restaurants, Inc.

 

4.55

 

02/15/48

 

23,514

 

475

 

Delta Air Lines, Inc.

 

3.625

 

03/15/22

 

469,434

 

450

 

Dollar Tree, Inc.

 

4.00

 

05/15/25

 

442,027

 

100

 

Dollar Tree, Inc.

 

4.20

 

05/15/28

 

97,318

 

175

 

Ford Motor Co.

 

4.75

 

01/15/43

 

146,203

 

300

 

Ford Motor Credit Co., LLC

 

3.096

 

05/04/23

 

281,915

 

300

 

General Motors Co.

 

6.60

 

04/01/36

 

320,666

 

125

 

Home Depot, Inc. (The)

 

4.875

 

02/15/44

 

138,668

 

175

 

Home Depot, Inc. (The)

 

5.875

 

12/16/36

 

213,379

 

225

 

Jaguar Land Rover Automotive PLC (United Kingdom) (a)

 

4.50

 

10/01/27

 

185,580

 

150

 

Kohl’s Corp.

 

5.55

 

07/17/45

 

144,552

 

550

 

Sands China Ltd. (China) (a)

 

5.40

 

08/08/28

 

548,708

 

450

 

Starbucks Corp.

 

4.00

 

11/15/28

 

449,660

 

221

 

United Airlines Pass-Through Trust, Class A

 

4.30

 

02/15/27

 

225,373

 

200

 

Valeo SA, Series FRT (France)

 

0.00

(b)

06/16/21

 

187,750

 

200

 

Walmart, Inc.

 

3.625

 

12/15/47

 

187,669

 

300

 

Wyndham Destinations, Inc.

 

4.15

 

04/01/24

 

292,500

 

 

 

 

 

 

 

 

 

6,425,550

 

 

 

Consumer, Non-Cyclical (9.7%)

 

 

 

 

 

 

 

125

 

Abbott Laboratories

 

4.90

 

11/30/46

 

136,286

 

175

 

AbbVie, Inc.

 

4.70

 

05/14/45

 

168,763

 

51

 

Allergan Funding SCS

 

4.75

 

03/15/45

 

49,768

 

197

 

Amgen, Inc.

 

4.663

 

06/15/51

 

195,708

 

600

 

Anheuser-Busch InBev Finance, Inc. (Belgium)

 

4.90

 

02/01/46

 

609,061

 

300

 

Ashtead Capital, Inc. (United Kingdom) (a)

 

4.125

 

08/15/25

 

286,500

 

200

 

Ashtead Capital, Inc. (United Kingdom) (a)

 

5.25

 

08/01/26

 

202,550

 

50

 

AstraZeneca PLC (United Kingdom)

 

6.45

 

09/15/37

 

62,955

 

200

 

Bayer US Finance II LLC (Germany) (a)

 

4.375

 

12/15/28

 

196,348

 

175

 

Biogen, Inc.

 

5.20

 

09/15/45

 

186,355

 

100

 

Celgene Corp.

 

4.55

 

02/20/48

 

93,408

 

250

 

Cencosud SA (Chile) (a)

 

6.625

 

02/12/45

 

252,577

 

175

 

Cigna Corp.

 

3.875

 

10/15/47

 

149,873

 

225

 

DP World Ltd. (United Arab Emirates) (a)

 

5.625

 

09/25/48

 

223,334

 

150

 

Elanco Animal Health, Inc. (a)

 

4.90

 

08/28/28

 

152,586

 

312

 

EMD Finance LLC (Germany) (a)

 

3.25

 

03/19/25

 

297,482

 

100

 

Express Scripts Holding Co.

 

4.50

 

02/25/26

 

101,049

 

225

 

Gilead Sciences, Inc.

 

4.80

 

04/01/44

 

233,107

 

275

 

Grupo Bimbo SAB de CV (Mexico) (a)

 

3.875

 

06/27/24

 

271,561

 

399

 

Halfmoon Parent, Inc. (a)

 

4.375

 

10/15/28

 

398,639

 

215

 

HCA, Inc.

 

4.50

 

02/15/27

 

210,969

 

250

 

Humana, Inc.

 

3.95

 

03/15/27

 

246,162

 

125

 

Keurig Dr Pepper, Inc. (a)

 

5.085

 

05/25/48

 

127,517

 

300

 

Kraft Heinz Foods Co.

 

4.375

 

06/01/46

 

265,966

 

175

 

Kroger Co. (The)

 

4.45

 

02/01/47

 

160,858

 

200

 

Medtronic, Inc.

 

4.625

 

03/15/45

 

212,320

 

150

 

Novartis Capital Corp. (Switzerland)

 

4.40

 

05/06/44

 

160,389

 

350

 

Pfizer, Inc.

 

3.00

 

12/15/26

 

336,380

 

200

 

Philip Morris International, Inc.

 

4.50

 

03/20/42

 

195,284

 

75

 

Teva Pharmaceutical Finance Netherlands III BV (Israel)

 

2.80

 

07/21/23

 

66,856

 

325

 

Teva Pharmaceutical Finance Netherlands III BV (Israel)

 

6.75

 

03/01/28

 

343,419

 

325

 

Thermo Fisher Scientific, Inc.

 

2.95

 

09/19/26

 

301,499

 

175

 

Transurban Finance Co., Pty Ltd. (Australia) (a)

 

3.375

 

03/22/27

 

162,490

 

300

 

Transurban Finance Co., Pty Ltd. (Australia) (a)

 

4.125

 

02/02/26

 

295,147

 

700

 

UnitedHealth Group, Inc.

 

3.75

 

07/15/25

 

703,957

 

 

 

 

 

 

 

 

 

8,057,123

 

 


 

 

 

Diversified (0.2%)

 

 

 

 

 

 

 

200

 

Alfa SAB de CV (Mexico) (a)

 

5.25

 

03/25/24

 

205,210

 

 

 

 

 

 

 

 

 

 

 

 

 

Energy (8.6%)

 

 

 

 

 

 

 

450

 

Andeavor

 

4.75

 

12/15/23

 

465,051

 

175

 

Andeavor Logistics LP/Tesoro Logistics Finance Corp.

 

5.20

 

12/01/47

 

175,410

 

400

 

APT Pipelines Ltd. (Australia) (a)

 

4.20

 

03/23/25

 

396,278

 

200

 

BG Energy Capital PLC (United Kingdom) (a)

 

5.125

 

10/15/41

 

216,252

 

500

 

BP Capital Markets PLC (United Kingdom)

 

3.119

 

05/04/26

 

477,251

 

300

 

Buckeye Partners LP

 

4.125

 

12/01/27

 

277,783

 

300

 

Cenovus Energy, Inc. (Canada)

 

4.25

 

04/15/27

 

290,507

 

250

 

Cimarex Energy Co.

 

3.90

 

05/15/27

 

239,257

 

650

 

Columbia Pipeline Group, Inc.

 

4.50

 

06/01/25

 

658,055

 

375

 

Concho Resources, Inc.

 

3.75

 

10/01/27

 

358,610

 

125

 

Concho Resources, Inc.

 

4.85

 

08/15/48

 

125,875

 

325

 

ConocoPhillips Co.

 

4.95

 

03/15/26

 

351,127

 

50

 

Energy Transfer Partners LP

 

5.15

 

03/15/45

 

47,367

 

300

 

Energy Transfer Partners LP

 

5.30

 

04/15/47

 

291,702

 

175

 

Enterprise Products Operating LLC

 

5.95

 

02/01/41

 

203,284

 

250

 

Exxon Mobil Corp.

 

4.114

 

03/01/46

 

254,051

 

125

 

Halliburton Co.

 

5.00

 

11/15/45

 

133,997

 

200

 

Kinder Morgan, Inc.

 

5.55

 

06/01/45

 

212,138

 

325

 

MPLX LP

 

4.00

 

02/15/25

 

320,922

 

25

 

MPLX LP

 

4.875

 

06/01/25

 

25,854

 

150

 

MPLX LP

 

5.20

 

03/01/47

 

150,854

 

200

 

Patterson-UTI Energy, Inc.

 

3.95

 

02/01/28

 

185,393

 

100

 

Phillips 66 Partners LP

 

4.68

 

02/15/45

 

95,118

 

175

 

Plains All American Pipeline LP/PAA Finance Corp.

 

4.50

 

12/15/26

 

175,119

 

200

 

Rockies Express Pipeline LLC (a)

 

6.875

 

04/15/40

 

229,000

 

450

 

Santos Finance Ltd. (Australia)

 

4.125

 

09/14/27

 

417,679

 

450

 

Woodside Finance Ltd. (Australia) (a)

 

3.70

 

09/15/26

 

428,600

 

 

 

 

 

 

 

 

 

7,202,534

 

 

 

Finance (34.7%)

 

 

 

 

 

 

 

600

 

ABN AMRO Bank N.V. (Netherlands) (a)

 

4.75

 

07/28/25

 

602,695

 

150

 

AerCap Ireland Capital DAC/AerCap Global Aviation Trust (Ireland)

 

3.50

 

05/26/22

 

147,295

 

350

 

AerCap Ireland Capital DAC/AerCap Global Aviation Trust (Ireland)

 

4.125

 

07/03/23

 

347,794

 

225

 

Air Lease Corp.

 

2.625

 

07/01/22

 

215,553

 

275

 

Alexandria Real Estate Equities, Inc.

 

3.95

 

01/15/27

 

265,652

 

300

 

American International Group, Inc.

 

4.50

 

07/16/44

 

284,187

 

275

 

Assurant, Inc.

 

4.20

 

09/27/23

 

273,772

 

250

 

Bank of America Corp.

 

3.97

 

03/05/29

 

244,212

 

625

 

Bank of America Corp.

 

4.244

 

04/24/38

 

611,312

 

205

 

Bank of America Corp.

 

7.75

 

05/14/38

 

277,492

 

625

 

Bank of America Corp., MTN

 

4.25

 

10/22/26

 

618,463

 

550

 

BNP Paribas SA (France) (a)

 

4.40

 

08/14/28

 

540,804

 

400

 

Boston Properties LP

 

3.65

 

02/01/26

 

388,130

 

250

 

BPCE SA (France) (a)

 

4.00

 

09/12/23

 

246,900

 

625

 

BPCE SA (France) (a)

 

5.15

 

07/21/24

 

636,434

 

450

 

Brighthouse Financial, Inc., Series WI

 

3.70

 

06/22/27

 

400,208

 

450

 

Brixmor Operating Partnership LP

 

4.125

 

06/15/26

 

437,013

 

400

 

Brookfield Finance, Inc. (Canada)

 

4.25

 

06/02/26

 

395,554

 

275

 

Capital One Financial Corp.

 

3.30

 

10/30/24

 

262,157

 

625

 

Capital One Financial Corp.

 

3.75

 

03/09/27

 

591,007

 

425

 

Citigroup, Inc.

 

4.45

 

09/29/27

 

420,551

 

225

 

Citigroup, Inc.

 

4.75

 

05/18/46

 

220,304

 

350

 

Citigroup, Inc.

 

8.125

 

07/15/39

 

506,705

 

200

 

Commerzbank AG (Germany) (a)

 

8.125

 

09/19/23

 

228,315

 

400

 

Compass Bank

 

3.50

 

06/11/21

 

398,232

 

575

 

Credit Agricole SA (France) (a)

 

3.75

 

04/24/23

 

564,870

 

 


 

250

 

Credit Agricole SA (France) (a)

 

4.125

 

01/10/27

 

242,317

 

250

 

Credit Suisse Group AG (Switzerland) (a)

 

3.574

 

01/09/23

 

245,239

 

400

 

Crown Castle International Corp.

 

3.80

 

02/15/28

 

380,081

 

150

 

CubeSmart LP

 

3.125

 

09/01/26

 

137,104

 

450

 

Deutsche Bank AG (Germany)

 

2.70

 

07/13/20

 

440,994

 

225

 

Deutsche Bank AG (Germany)

 

3.15

 

01/22/21

 

219,992

 

425

 

Discover Bank

 

7.00

 

04/15/20

 

445,644

 

300

 

Discover Financial Services

 

3.95

 

11/06/24

 

293,703

 

175

 

Extra Space Storage LP (a)

 

3.125

 

10/01/35

 

185,663

 

450

 

Five Corners Funding Trust (a)

 

4.419

 

11/15/23

 

462,338

 

500

 

GE Capital International Funding Co., Unlimited Co.

 

4.418

 

11/15/35

 

471,406

 

375

 

Goldman Sachs Group, Inc. (The)

 

6.25

 

02/01/41

 

451,599

 

525

 

Goldman Sachs Group, Inc. (The)

 

6.75

 

10/01/37

 

632,635

 

300

 

Goldman Sachs Group, Inc. (The), MTN

 

4.80

 

07/08/44

 

306,843

 

150

 

Great-West Lifeco Finance 2018 LP (Canada) (a)

 

4.581

 

05/17/48

 

152,116

 

250

 

Guardian Life Insurance Co. of America (The) (a)

 

4.85

 

01/24/77

 

245,794

 

400

 

Healthcare Trust of America Holdings LP

 

3.70

 

04/15/23

 

392,591

 

375

 

High Street Funding Trust I (a)

 

4.111

 

02/15/28

 

366,675

 

525

 

HSBC Holdings PLC (United Kingdom)

 

3.90

 

05/25/26

 

509,627

 

425

 

HSBC Holdings PLC (United Kingdom)

 

3.95

 

05/18/24

 

422,489

 

250

 

HSBC Holdings PLC (United Kingdom)

 

4.375

 

11/23/26

 

246,129

 

400

 

ING Bank N.V. (Netherlands) (a)

 

5.80

 

09/25/23

 

422,194

 

200

 

ING Groep N.V. (Netherlands)

 

6.00

 

04/16/20(c)

 

199,980

 

250

 

iStar, Inc.

 

5.25

 

09/15/22

 

246,875

 

175

 

JPMorgan Chase & Co.

 

3.782

 

02/01/28

 

170,485

 

200

 

JPMorgan Chase & Co.

 

3.897

 

01/23/49

 

181,021

 

480

 

JPMorgan Chase & Co.

 

4.95

 

06/01/45

 

504,488

 

575

 

LeasePlan Corp. N.V. (Netherlands) (a)

 

2.875

 

01/22/19

 

574,605

 

275

 

Lincoln National Corp.

 

7.00

 

06/15/40

 

346,145

 

275

 

Lloyds Banking Group PLC (United Kingdom)

 

3.574

 

11/07/28

 

252,378

 

400

 

Lloyds Banking Group PLC (United Kingdom)

 

3.75

 

01/11/27

 

376,609

 

250

 

Lloyds Banking Group PLC (United Kingdom)

 

4.375

 

03/22/28

 

244,333

 

200

 

Lloyds Banking Group PLC (United Kingdom)

 

4.55

 

08/16/28

 

197,557

 

450

 

Macquarie Group Ltd. (Australia) (a)

 

4.15

 

03/27/24

 

448,560

 

125

 

Massachusetts Mutual Life Insurance Co. (a)

 

4.50

 

04/15/65

 

117,164

 

250

 

MetLife, Inc. (d)

 

5.70

 

06/15/35

 

287,318

 

250

 

MPT Operating Partnership LP/MPT Finance Corp.

 

5.00

 

10/15/27

 

241,562

 

300

 

Nationwide Building Society (United Kingdom) (a)

 

4.302

 

03/08/29

 

287,575

 

425

 

Nationwide Building Society (United Kingdom) (a)

 

4.363

 

08/01/24

 

423,232

 

275

 

Northern Trust Corp.

 

3.375

 

05/08/32

 

256,613

 

150

 

Prologis LP

 

3.875

 

09/15/28

 

150,866

 

575

 

Realty Income Corp.

 

3.25

 

10/15/22

 

568,163

 

575

 

Royal Bank of Scotland Group PLC (United Kingdom)

 

3.875

 

09/12/23

 

559,153

 

750

 

Santander UK Group Holdings PLC (United Kingdom)

 

3.571

 

01/10/23

 

729,381

 

325

 

Santander UK PLC (United Kingdom) (a)

 

5.00

 

11/07/23

 

328,137

 

125

 

Spirit Realty Capital, Inc.

 

3.75

 

05/15/21

 

126,318

 

50

 

Synchrony Financial

 

3.70

 

08/04/26

 

45,235

 

425

 

Synchrony Financial

 

3.95

 

12/01/27

 

385,729

 

125

 

TD Ameritrade Holding Corp.

 

3.30

 

04/01/27

 

119,852

 

350

 

TD Ameritrade Holding Corp.

 

3.625

 

04/01/25

 

344,538

 

525

 

UBS Group Funding Switzerland AG (Switzerland) (a)

 

3.491

 

05/23/23

 

514,753

 

125

 

Visa, Inc.

 

4.30

 

12/14/45

 

129,560

 

325

 

WEA Finance LLC/Westfield UK & Europe Finance PLC (a)

 

3.25

 

10/05/20

 

324,055

 

1,350

 

Wells Fargo & Co.

 

3.00

 

10/23/26

 

1,254,054

 

250

 

Wells Fargo & Co., MTN

 

4.10

 

06/03/26

 

247,362

 

 

 

 

 

 

 

 

 

28,982,440

 

 

 

Industrials (4.4%)

 

 

 

 

 

 

 

375

 

Burlington Northern Santa Fe LLC

 

4.55

 

09/01/44

 

391,109

 

 


 

250

 

CSX Corp.

 

3.80

 

03/01/28

 

246,927

 

165

 

Embraer Netherlands Finance BV (Brazil)

 

5.40

 

02/01/27

 

168,506

 

350

 

Fortune Brands Home & Security, Inc.

 

4.00

 

09/21/23

 

351,490

 

225

 

General Electric Co., Series D

 

5.00

 

01/21/21(c)

 

219,487

 

200

 

Harris Corp.

 

4.854

 

04/27/35

 

205,829

 

510

 

Heathrow Funding Ltd. (United Kingdom) (a)

 

4.875

 

07/15/23

 

529,681

 

225

 

Lockheed Martin Corp.

 

3.55

 

01/15/26

 

222,716

 

425

 

Nvent Finance Sarl (Luxembourg) (a)

 

3.95

 

04/15/23

 

417,932

 

250

 

Trimble, Inc.

 

4.90

 

06/15/28

 

251,893

 

125

 

Tyco Electronics Group SA (Switzerland)

 

3.125

 

08/15/27

 

116,466

 

165

 

Union Pacific Corp.

 

3.95

 

09/10/28

 

166,057

 

375

 

Wabtec Corp.

 

4.70

 

09/15/28

 

369,783

 

 

 

 

 

 

 

 

 

3,657,876

 

 

 

Technology (4.7%)

 

 

 

 

 

 

 

175

 

Akamai Technologies, Inc.

 

0.00

(b)

02/15/19

 

174,011

 

425

 

Apple, Inc.

 

2.45

 

08/04/26

 

392,343

 

225

 

Apple, Inc.

 

3.00

 

06/20/27

 

214,356

 

400

 

Apple, Inc.

 

3.85

 

08/04/46

 

384,550

 

200

 

Dell International LLC/EMC Corp. (a)

 

8.10

 

07/15/36

 

240,617

 

250

 

Electronics For Imaging, Inc.

 

0.75

 

09/01/19

 

246,996

 

200

 

Fiserv, Inc.

 

4.20

 

10/01/28

 

200,818

 

275

 

Intel Corp.

 

2.60

 

05/19/26

 

256,933

 

525

 

Microsoft Corp.

 

4.45

 

11/03/45

 

564,447

 

250

 

Nuance Communications, Inc.

 

1.00

 

12/15/35

 

236,477

 

200

 

NXP Semiconductors NV (Netherlands)

 

1.00

 

12/01/19

 

208,746

 

200

 

Oracle Corp.

 

3.80

 

11/15/37

 

190,916

 

350

 

Oracle Corp.

 

4.00

 

11/15/47

 

333,188

 

250

 

Verint Systems, Inc.

 

1.50

 

06/01/21

 

258,732

 

 

 

 

 

 

 

 

 

3,903,130

 

 

 

Utilities (10.4%)

 

 

 

 

 

 

 

250

 

Abu Dhabi National Energy Co., PJSC (United Arab Emirates) (a)

 

4.375

 

06/22/26

 

247,450

 

400

 

Alabama Power Co.

 

3.75

 

03/01/45

 

367,560

 

475

 

Appalachian Power Co.

 

3.40

 

06/01/25

 

464,126

 

175

 

Black Hills Corp.

 

3.15

 

01/15/27

 

161,185

 

75

 

Black Hills Corp.

 

4.35

 

05/01/33

 

73,658

 

250

 

Boston Gas Co. (a)

 

4.487

 

02/15/42

 

252,953

 

275

 

Duke Energy Carolinas LLC

 

3.75

 

06/01/45

 

254,211

 

275

 

Duke Energy Corp.

 

2.65

 

09/01/26

 

249,077

 

550

 

EDP Finance BV (Portugal) (a)

 

3.625

 

07/15/24

 

526,254

 

350

 

Electricite de France SA (France) (a)

 

4.50

 

09/21/28

 

345,184

 

450

 

Emera US Finance LP (Canada)

 

3.55

 

06/15/26

 

424,534

 

125

 

Enel Chile SA (Chile)

 

4.875

 

06/12/28

 

126,425

 

275

 

Enel Finance International N.V. (Italy) (a)

 

4.875

 

06/14/29

 

266,130

 

225

 

Enel Finance International N.V. (Italy) (a)

 

6.00

 

10/07/39

 

245,464

 

410

 

Enel SpA (Italy) (a)

 

8.75

 

09/24/73

 

455,100

 

300

 

Entergy Arkansas, Inc.

 

3.50

 

04/01/26

 

295,891

 

150

 

Entergy Louisiana LLC

 

3.05

 

06/01/31

 

136,341

 

300

 

Fortis, Inc., Series WI (Canada)

 

2.10

 

10/04/21

 

286,799

 

50

 

Indiana Michigan Power Co.

 

4.25

 

08/15/48

 

49,466

 

275

 

Mid-Atlantic Interstate Transmission LLC (a)

 

4.10

 

05/15/28

 

273,045

 

250

 

Mississippi Power Co.

 

3.95

 

03/30/28

 

245,124

 

450

 

NextEra Energy Capital Holdings, Inc.

 

3.55

 

05/01/27

 

433,744

 

325

 

Origin Energy Finance Ltd. (Australia) (a)

 

3.50

 

10/09/18

 

324,995

 

200

 

Pacific Gas & Electric Co.

 

3.95

 

12/01/47

 

174,562

 

250

 

South Carolina Electric & Gas Co.

 

4.50

 

06/01/64

 

230,199

 

150

 

Southern California Edison Co.

 

4.00

 

04/01/47

 

141,245

 

525

 

Trans-Allegheny Interstate Line Co. (a)

 

3.85

 

06/01/25

 

520,611

 

396

 

TransAlta Corp. (Canada)

 

4.50

 

11/15/22

 

389,120

 

475

 

Virginia Electric & Power Co., Series B

 

4.20

 

05/15/45

 

464,493

 

 


 

250

 

Xcel Energy, Inc.

 

3.30

 

06/01/25

 

241,992

 

 

 

 

 

 

 

 

 

8,666,938

 

 

 

Total Corporate Bonds (Cost $81,690,162)

 

 

 

 

 

80,409,445

 

 

 

 

 

 

 

 

 

 

 

 

 

Short-Term Investments (2.8%)

 

 

 

 

 

 

 

 

 

U.S. Treasury Security (1.0%)

 

 

 

 

 

 

 

889

 

U.S. Treasury Bill (e)(f) (Cost $887,484)

 

2.022

 

11/01/18

 

887,484

 

 

NUMBER OF
SHARES
(000)

 

 

 

 

 

 

 

 

 

 

 

Investment Company (1.8%)

 

 

 

 

 

 

 

1,477

 

Morgan Stanley Institutional Liquidity Funds - Government Portfolio - Institutional Class (g) (Cost $1,476,978)

 

 

 

1,476,978

 

 

 

Total Short-Term Investments (Cost $2,364,462)

 

 

 

2,364,462

 

 

 

 

 

 

 

 

 

 

 

Total Investments (Cost $84,054,624) (h)(i)(j)

 

99.2

%

82,773,907

 

 

 

Other Assets in Excess of Liabilities

 

 

 

0.8

 

632,380

 

 

 

Net Assets

 

 

 

100.0

%

$

83,406,287

 

 


MTN

 

Medium Term Note.

PJSC

 

Public Joint Stock Company.

(a)

 

144A security — Certain conditions for public sale may exist. Unless otherwise noted, these securities are deemed to be liquid.

(b)

 

Capital appreciation bond.

(c)

 

Perpetual — One or more securities do not have a predetermined maturity date. Rates for these securities are fixed for a period of time, after which they revert to a floating rate. Interest rates in effect are as of September 30, 2018.

(d)

 

For the nine months ended September 30, 2018, there were no transactions in Met Life, Inc., Corporate Bond, and its affiliated broker-dealers, which may be deemed affiliates of the Adviser/Administrator and Distributor.

(e)

 

All or a portion of the security was pledged to cover margin requirements for futures contracts and swap agreements.

(f)

 

Rate shown is the yield to maturity at September 30, 2018.

(g)

 

The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Government Portfolio - (the “Liquidity Funds”), an open-end management investment company managed by the Adviser. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2018, advisory fees paid were reduced by $838 relating to the Fund’s investment in the Liquidity Funds.

(h)

 

Securities are available for collateral in connection with purchase of open futures contracts and swap agreements.

(i)

 

The Fund is permitted to purchase and sell securities (“cross-trade”) from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the “Rule”). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2018, the Fund did not engage in any cross-trade transactions.

(j)

 

At September 30, 2018, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $1,267,754 and the aggregate gross unrealized depreciation is $2,311,353, resulting in net unrealized depreciation of $1,043,599.

 


 

Futures Contracts:

The Fund had the following futures contracts open at September 30, 2018:

 

 

 

Number
of
Contracts

 

Expiration
Date

 

Notional Amount
(000)

 

Value

 

Unrealized
Appreciation
(Depreciation)

 

Long:

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury 2 yr. Note

 

96

 

Dec-18

 

19,200

 

$

20,230,500

 

$

(61,312

)

U.S. Treasury 30 yr. Bond

 

16

 

Dec-18

 

1,600

 

2,248,000

 

(65,781

)

U.S. Treasury Ultra Bond

 

4

 

Dec-18

 

400

 

617,125

 

(5,157

)

Short:

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasury 10 yr. Note

 

14

 

Dec-18

 

(1,400

)

(1,662,937

)

19,114

 

U.S. Treasury 5 yr. Note

 

35

 

Dec-18

 

(3,500

)

(3,936,680

)

24,266

 

U.S. Treasury 10 yr. Ultra Long Bond

 

55

 

Dec-18

 

(5,500

)

(6,930,000

)

109,445

 

 

 

 

 

 

 

 

 

 

 

$

20,575

 

 

Credit Default Swap Agreement:

The Fund had the following credit default swap agreement open at September 30, 2018:

 

Swap Counterparty and
Reference Obligation

 

Credit
Rating of
Reference
Obligation†

 

Buy/Sell
Protection

 

Pay/Receive
Fixed Rate

 

Payment
Frequency

 

Maturity
Date

 

Notional
Amount
(000)

 

Value

 

Upfront
Payment
Received

 

Unrealized
Depreciation

 

Morgan Stanley & Co., LLC*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CDX.NA.HY.30

 

NR

 

Buy

 

5.00

%

Quarterly

 

6/20/23

 

$

1,250

 

$

(99,575

)

$

(79,448

)

$

(20,127

)

 

Interest Rate Swap Agreement:

The Fund had the following interest rate swap agreement open at September 30, 2018:

 

Swap Counterparty

 

Floating Rate
Index

 

Pay/Receive
Floating Rate

 

Fixed
Rate

 

Payment
Frequency
Paid/Received

 

Maturity
Date

 

Notional
Amount
(000)

 

Value

 

Upfront
Payment Paid

 

Unrealized
Appreciation

 

Morgan Stanley & Co., LLC*

 

3 Month LIBOR

 

Receive

 

2.48

%

Semi- Annual/Quarterly

 

12/21/26

 

$

5,897

 

$

236,670

 

$

 

$

236,670

 

 


 

Credit rating as issued by Standard & Poor’s.

*

 

Cleared swap agreement, the broker is Morgan Stanley & Co., LLC.

NR

 

Not rated.

LIBOR

 

London Interbank Offered Rate.

 


 

Morgan Stanley Variable Investment Series - European Equity Portfolio

Portfolio of Investments · September 30, 2018 (unaudited)

 

NUMBER OF
SHARES

 

 

 

VALUE

 

 

 

Common Stocks (99.0%)

 

 

 

 

 

Denmark (2.3%)

 

 

 

 

 

Pharmaceuticals

 

 

 

12,416

 

Novo Nordisk A/S, Series B

 

$

584,564

 

 

 

 

 

 

 

 

 

France (15.0%)

 

 

 

 

 

Aerospace & Defense

 

 

 

6,715

 

Airbus SE

 

843,420

 

 

 

 

 

 

 

 

 

Banks

 

 

 

10,389

 

BNP Paribas SA

 

635,796

 

 

 

 

 

 

 

 

 

Electrical Equipment

 

 

 

8,254

 

Schneider Electric SE

 

664,124

 

 

 

 

 

 

 

 

 

Health Care Equipment & Supplies

 

 

 

3,604

 

Essilor International Cie Generale d’Optique SA

 

533,305

 

 

 

 

 

 

 

 

 

Hotels, Restaurants & Leisure

 

 

 

10,535

 

Accor SA

 

540,884

 

 

 

 

 

 

 

 

 

Insurance

 

 

 

23,998

 

AXA SA

 

645,026

 

 

 

Total France

 

3,862,555

 

 

 

 

 

 

 

 

 

Germany (15.4%)

 

 

 

 

 

Air Freight & Logistics

 

 

 

10,880

 

Deutsche Post AG (Registered)

 

387,936

 

 

 

 

 

 

 

 

 

Auto Components

 

 

 

2,210

 

Continental AG

 

384,760

 

 

 

 

 

 

 

 

 

Chemicals

 

 

 

2,000

 

Linde AG

 

473,012

 

6,199

 

Symrise AG

 

565,856

 

 

 

 

 

1,038,868

 

 

 

Health Care Providers & Services

 

 

 

8,333

 

Fresenius SE & Co., KGaA

 

611,849

 

 

 

 

 

 

 

 

 

Pharmaceuticals

 

 

 

6,676

 

Bayer AG (Registered)

 

593,042

 

 

 

 

 

 

 

 

 

Software

 

 

 

7,797

 

SAP SE

 

959,587

 

 

 

Total Germany

 

3,976,042

 

 

 

 

 

 

 

 

 

Ireland (2.0%)

 

 

 

 

 

Construction Materials

 

 

 

16,152

 

CRH PLC

 

528,468

 

 

 

 

 

 

 

 

 

Italy (1.1%)

 

 

 

 

 

Capital Markets

 

 

 

18,727

 

Azimut Holding SpA (a)

 

282,659

 

 

 

 

 

 

 

 

 

Netherlands (9.0%)

 

 

 

 

 

Banks

 

 

 

37,134

 

ING Groep N.V.

 

482,192

 

 

 

 

 

 

 

 

 

Food & Staples Retailing

 

 

 

21,420

 

Koninklijke Ahold Delhaize N.V.

 

491,177

 

 

 

 

 

 

 

 

 

Personal Products

 

 

 

12,857

 

Unilever N.V. CVA

 

716,003

 

 

 

 

 

 

 

 

 

Semiconductors & Semiconductor Equipment

 

 

 

3,440

 

ASML Holding N.V.

 

642,637

 

 

 

Total Netherlands

 

2,332,009

 

 

 

 

 

 

 

 

 

Spain (3.7%)

 

 

 

 

 

Electrical Equipment

 

 

 

24,303

 

Siemens Gamesa Renewable Energy SA (a)(b)

 

307,565

 

 


 

NUMBER OF
SHARES

 

 

 

VALUE

 

 

 

Information Technology Services

 

 

 

6,999

 

Amadeus IT Group SA

 

$

650,258

 

 

 

Total Spain

 

957,823

 

 

 

 

 

 

 

 

 

Sweden (4.2%)

 

 

 

 

 

Banks

 

 

 

47,524

 

Nordea Bank AB

 

517,944

 

 

 

 

 

 

 

 

 

Machinery

 

 

 

31,454

 

Volvo AB, Class B

 

556,003

 

 

 

Total Sweden

 

1,073,947

 

 

 

 

 

 

 

 

 

Switzerland (17.4%)

 

 

 

 

 

Capital Markets

 

 

 

39,321

 

UBS Group AG (Registered) (b)

 

621,027

 

 

 

 

 

 

 

 

 

Chemicals

 

 

 

3,728

 

Sika AG (Registered)

 

542,828

 

 

 

 

 

 

 

 

 

Food Products

 

 

 

14,054

 

Nestle SA (Registered)

 

1,171,692

 

 

 

 

 

 

 

 

 

Insurance

 

 

 

2,165

 

Zurich Insurance Group AG

 

684,311

 

 

 

 

 

 

 

 

 

Pharmaceuticals

 

 

 

11,523

 

Novartis AG (Registered)

 

990,973

 

 

 

 

 

 

 

 

 

Textiles, Apparel & Luxury Goods

 

 

 

5,763

 

Cie Financiere Richemont SA (Registered)

 

469,778

 

 

 

Total Switzerland

 

4,480,609

 

 

 

 

 

 

 

 

 

United Kingdom (28.9%)

 

 

 

 

 

Banks

 

 

 

819,447

 

Lloyds Banking Group PLC

 

633,044

 

 

 

 

 

 

 

 

 

Diversified Telecommunication Services

 

 

 

141,505

 

BT Group PLC

 

415,538

 

 

 

 

 

 

 

 

 

Equity Real Estate Investment Trusts (REITs)

 

 

 

32,153

 

Great Portland Estates PLC REIT

 

280,408

 

 

 

 

 

 

 

 

 

Hotels, Restaurants & Leisure

 

 

 

26,635

 

Compass Group PLC

 

592,256

 

 

 

 

 

 

 

 

 

Household Products

 

 

 

8,219

 

Reckitt Benckiser Group PLC

 

751,600

 

 

 

 

 

 

 

 

 

Insurance

 

 

 

29,786

 

Prudential PLC

 

683,092

 

 

 

 

 

 

 

 

 

Media

 

 

 

177,717

 

ITV PLC

 

365,638

 

 

 

 

 

 

 

 

 

Oil, Gas & Consumable Fuels

 

 

 

128,587

 

BP PLC

 

987,669

 

28,432

 

Royal Dutch Shell PLC, Class A

 

977,041

 

 

 

 

 

1,964,710

 

 

 

Professional Services

 

 

 

22,401

 

RELX PLC (b)

 

470,627

 

 

 

 

 

 

 

 

 

Tobacco

 

 

 

16,633

 

British American Tobacco PLC

 

777,100

 

14,480

 

Imperial Brands PLC

 

504,104

 

 

 

 

 

1,281,204

 

 

 

Total United Kingdom

 

7,438,117

 

 

 

Total Common Stocks (Cost $19,594,719)

 

25,516,793

 

 


 

NUMBER OF
SHARES
(000)

 

 

 

VALUE

 

 

 

Short-Term Investments (2.1%)

 

 

 

 

 

Securities held as Collateral on Loaned Securities (1.5%)

 

 

 

 

 

Investment Company (1.2%)

 

 

 

325

 

Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class (c)

 

$

324,961

 

 

PRINCIPAL
AMOUNT
(000)

 

 

 

 

 

 

 

Repurchase Agreements (0.3%)

 

 

 

$

43

 

HSBC Securities USA, Inc. (2.23%, dated 09/28/18, due 10/01/18; proceeds $42,766; fully collateralized by U.S. Government obligations; 0.00% - 2.75% due 05/15/25 - 08/15/47; valued at $43,613)

 

42,758

 

37

 

Merrill Lynch & Co., Inc. (2.25%, dated 09/28/18, due 10/01/18; proceeds $37,064; fully collateralized by U.S. Government obligations; 0.75% - 3.00% due 02/15/42 - 11/15/45; valued at $37,798)

 

37,057

 

 

 

 

 

79,815

 

 

 

Total Securities held as Collateral on Loaned Securities (Cost $404,776)

 

404,776

 

 

NUMBER OF
SHARES
(000)

 

 

 

 

 

 

 

Investment Company (0.6%)

 

 

 

152

 

Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class (c) (Cost $152,180)

 

152,180

 

 

 

Total Short-Term Investments (Cost $556,956)

 

556,956

 

 

 

Total Investments (Cost $20,151,675) (d)(e)

 

101.1

%

26,073,749

 

 

 

Liabilities in Excess of Other Assets

 

(1.1

)

(291,425

)

 

 

Net Assets

 

100.0

%

$

25,782,324

 

 

Country assignments and aggregations are based generally on third party vendor classifications and information, and may be different from the assignments and aggregations under the policies set forth in the Fund’s prospectus and/or statement of additional information relating to geographic classifications.

 


CVA

 

Certificaten Van Aandelen.

REIT

 

Real Estate Investment Trust.

(a)

 

All or a portion of this security was on loan. The value of loaned securities and related collateral outstanding at September 30, 2018, were $398,324 and $433,413, respectively. The Fund received cash collateral of $433,413, of which $404,776, which was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class as reported in the Portfolio of Investments. At September 30, 2018, there was uninvested cash of $28,637 which is not reflected in the Portfolio of Investments. The Fund has the right under the securities lending agreement to recover the securities from the borrower on demand.

(b)

 

Non-income producing security.

(c)

 

The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - (the “Liquidity Funds”), an open-end management investment company managed by the Adviser, both directly and as a portion of the securities held as collateral on loaned securities. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2018, advisory fees paid were reduced by $341 relating to the Fund’s investment in the Liquidity Funds.

 


 

(d)

 

The Fund is permitted to purchase and sell securities (“cross-trade”) from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the “Rule”). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2018, the Fund did not engage in any cross-trade transactions.

(e)

 

At September 30, 2018, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $6,922,894 and the aggregate gross unrealized depreciation is $1,000,820, resulting in net unrealized appreciation of $5,922,074.

 


 

Summary of Investments · September 30, 2018 (unaudited)

 

INDUSTRY

 

VALUE

 

PERCENT OF
TOTAL
INVESTMENTS

 

Banks

 

$

2,268,976

 

8.8

%

Pharmaceuticals

 

2,168,579

 

8.5

 

Insurance

 

2,012,429

 

7.8

 

Oil, Gas & Consumable Fuels

 

1,964,710

 

7.7

 

Chemicals

 

1,581,696

 

6.2

 

Tobacco

 

1,281,204

 

5.0

 

Food Products

 

1,171,692

 

4.6

 

Hotels, Restaurants & Leisure

 

1,133,140

 

4.4

 

Electrical Equipment

 

971,689

 

3.8

 

Software

 

959,587

 

3.7

 

Capital Markets

 

903,686

 

3.5

 

Aerospace & Defense

 

843,420

 

3.3

 

Household Products

 

751,600

 

2.9

 

Personal Products

 

716,003

 

2.8

 

Information Technology Services

 

650,258

 

2.5

 

Semiconductors & Semiconductor Equipment

 

642,637

 

2.5

 

Health Care Providers & Services

 

611,849

 

2.4

 

Machinery

 

556,003

 

2.2

 

Health Care Equipment & Supplies

 

533,305

 

2.1

 

Construction Materials

 

528,468

 

2.1

 

Food & Staples Retailing

 

491,177

 

1.9

 

Professional Services

 

470,627

 

1.8

 

Textiles, Apparel & Luxury Goods

 

469,778

 

1.8

 

Diversified Telecommunication Services

 

415,538

 

1.6

 

Air Freight & Logistics

 

387,936

 

1.5

 

Auto Components

 

384,760

 

1.5

 

Media

 

365,638

 

1.4

 

Equity Real Estate Investment Trusts (REITs)

 

280,408

 

1.1

 

Investment Company

 

152,180

 

0.6

 

 

 

$

25,668,973

+

100.0

%

 


+    Does not reflect the value of securities held as collateral on loaned securities.

 


 

Morgan Stanley Variable Investment Series - Multi Cap Growth Portfolio

Portfolio of Investments · September 30, 2018 (unaudited)

 

NUMBER OF
SHARES

 

 

 

VALUE

 

 

 

Common Stocks (93.6%)

 

 

 

 

 

Automobiles (1.0%)

 

 

 

424,530

 

NIO, Inc. ADR (a)(b)

 

$

2,963,219

 

 

 

 

 

 

 

 

 

 

Biotechnology (1.1%)

 

 

 

16,507

 

Alnylam Pharmaceuticals, Inc. (a)

 

1,444,692

 

2,393

 

Bluebird Bio, Inc. (a)

 

349,378

 

14,532

 

Editas Medicine, Inc. (a)

 

462,408

 

19,877

 

Intellia Therapeutics, Inc. (a)

 

568,880

 

32,504

 

Intrexon Corp. (a)(b)

 

559,719

 

 

 

 

 

3,385,077

 

 

 

Health Care Equipment & Supplies (10.8%)

 

 

 

76,816

 

DexCom, Inc. (a)

 

10,987,761

 

26,231

 

Intuitive Surgical, Inc. (a)

 

15,056,594

 

25,048

 

LivaNova PLC (a)

 

3,105,201

 

29,025

 

Penumbra, Inc. (a)

 

4,345,042

 

 

 

 

 

33,494,598

 

 

 

Health Care Providers & Services (4.7%)

 

 

 

156,085

 

HealthEquity, Inc. (a)

 

14,735,985

 

 

 

 

 

 

 

 

 

Health Care Technology (8.9%)

 

 

 

71,069

 

athenahealth, Inc. (a)

 

9,494,818

 

164,896

 

Veeva Systems, Inc., Class A (a)

 

17,952,228

 

 

 

 

 

27,447,046

 

 

 

Hotels, Restaurants & Leisure (4.1%)

 

 

 

225,599

 

Starbucks Corp.

 

12,823,047

 

 

 

 

 

 

 

 

 

Internet & Direct Marketing Retail (13.6%)

 

 

 

13,998

 

Amazon.com, Inc. (a)

 

28,037,994

 

236,974

 

Farfetch Ltd., Class A (a)

 

6,452,802

 

179,703

 

Overstock.com, Inc. (a)(b)

 

4,977,773

 

54,367

 

TripAdvisor, Inc. (a)

 

2,776,523

 

 

 

 

 

42,245,092

 

 

 

Internet Software & Services (20.0%)

 

 

 

13,936

 

Alibaba Group Holding Ltd. ADR (a)

 

2,296,095

 

201,866

 

Coupa Software, Inc. (a)

 

15,967,601

 

14,625

 

MercadoLibre, Inc.

 

4,979,374

 

150,661

 

Okta, Inc. (a)

 

10,600,508

 

62,756

 

Spotify Technology SA (a)

 

11,348,167

 

51,400

 

Tencent Holdings Ltd. (c)

 

2,122,092

 

409,862

 

Twitter, Inc. (a)

 

11,664,673

 

68,763

 

Zillow Group, Inc., Class C (a)

 

3,042,763

 

 

 

 

 

62,021,273

 

 

 

Life Sciences Tools & Services (5.6%)

 

 

 

46,924

 

Illumina, Inc. (a)

 

17,223,923

 

 

 

 

 

 

 

 

 

Pharmaceuticals (0.1%)

 

 

 

5,181

 

Nektar Therapeutics (a)

 

315,834

 

 

 

 

 

 

 

 

 

Road & Rail (5.0%)

 

 

 

95,090

 

Union Pacific Corp.

 

15,483,505

 

 

 

 

 

 

 

 

 

Software (18.7%)

 

 

 

168,858

 

Activision Blizzard, Inc.

 

14,047,297

 

94,711

 

salesforce.com, Inc. (a)

 

15,061,890

 

73,803

 

ServiceNow, Inc. (a)

 

14,438,081

 

99,000

 

Workday, Inc., Class A (a)

 

14,452,020

 

 

 

 

 

57,999,288

 

 

 

Total Common Stocks (Cost $190,541,740)

 

290,137,887

 

 


 

 

 

Preferred Stocks (4.5%)

 

 

 

 

 

Electronic Equipment, Instruments & Components (0.2%)

 

 

 

18,954

 

Magic Leap, Series C (a)(d)(e)(f)  (acquisition cost - $436,567; acquired 12/22/15)

 

511,758

 

 

 

 

 

 

 

 

 

Internet & Direct Marketing Retail (2.2%)

 

 

 

42,717

 

Airbnb, Inc., Series D (a)(d)(e)(f)  (acquisition cost - $1,739,139; acquired 04/16/14)

 

4,485,285

 

50,711

 

Uber Technologies, Series G (a)(d)(e)(f)  (acquisition cost - $2,473,289; acquired 12/03/15)

 

2,228,748

 

 

 

 

 

6,714,033

 

 

 

Life Sciences Tools & Services (2.0%)

 

 

 

627,809

 

10X Genomics, Inc., Series B (a)(d)(e)(f)  (acquisition cost - $2,052,935; acquired 12/19/14)

 

6,290,646

 

 

 

 

 

 

 

 

 

Software (0.1%)

 

 

 

141,612

 

Lookout, Inc., Series F (a)(d)(e)(f)  (acquisition cost - $1,617,648; acquired 06/17/14)

 

253,486

 

 

 

Total Preferred Stocks (Cost $8,319,578)

 

13,769,923

 

 

NUMBER OF
SHARES
(000)

 

 

 

 

 

 

 

Short-Term Investments (4.7%)

 

 

 

 

 

Securities held as Collateral on Loaned Securities (2.6%)

 

 

 

 

 

Investment Company (2.1%)

 

 

 

6,574

 

Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class (g)

 

6,574,143

 

 

PRINCIPAL
AMOUNT
(000)

 

 

 

VALUE

 

 

 

Repurchase Agreements (0.5%)

 

 

 

$

865

 

HSBC Securities USA, Inc. (2.23%, dated 09/28/18, due 10/01/18; proceeds $865,180; fully collateralized by U.S. Government obligations; 0.00% - 2.75% due 05/15/25 - 08/15/47; valued at $882,322)

 

865,019

 

750

 

Merrill Lynch & Co., Inc. (2.25%, dated 09/28/18, due 10/01/18; proceeds $749,824; fully collateralized by U.S. Government obligations; 0.75% - 3.00% due 02/15/42 - 11/15/45; valued at $764,677)

 

749,683

 

 

 

 

 

1,614,702

 

 

 

Total Securities held as Collateral on Loaned Securities (Cost $8,188,845)

 

8,188,845

 

 

NUMBER OF
SHARES
(000)

 

 

 

 

 

 

 

Investment Company (2.1%)

 

 

 

6,436

 

Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class (g) (Cost $6,436,156)

 

6,436,156

 

 

 

Total Short-Term Investments (Cost $14,625,001)

 

14,625,001

 

 

 

Total Investments Excluding Purchased Options (Cost $213,486,319)

 

102.8%

 

318,532,811

 

 

 

Total Purchased Options Outstanding (Cost $825,520)

 

0.1%

 

314,372

 

 

 

Total Investments (Cost $214,311,839) (h)(i)

 

102.9%

 

318,847,183

 

 

 

Liabilities in Excess of Other Assets

 

(2.9)

 

(8,883,605

)

 

 

Net Assets

 

100.0%

 

$

309,963,578

 

 


 


ADR

 

American Depositary Receipt.

(a)

 

Non-income producing security.

(b)

 

All or a portion of this security was on loan. The value of loaned securities and related collateral outstanding at September 30, 2018, were $8,500,711 and $8,768,198 respectively. The Fund received cash collateral of $8,768,198, of which 8,188,845 was subsequently invested in Repurchase Agreements and Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - Institutional Class as reported in the Portfolio of Investments. At September 30, 2018, there was uninvested cash of $579,353 which is not reflected in the Portfolio of Investments. The Fund has the right under the securities lending agreement to recover the securities from the borrower on demand.

(c)

 

Security trades on the Hong Kong exchange.

(d)

 

At September 30, 2018, the Fund held fair valued securities valued at $13,769,923, representing 4.5% of net assets. These securities have been fair valued as determined in good faith under procedures established by and under the general supervision of the Trust’s Trustees.

(e)

 

Illiquid security.

(f)

 

Security cannot be offered for public resale without first being registered under the Securities Act of 1933 and related rules (“restricted security”). Acquisition date represents the day on which an enforceable right to acquire such security is obtained and is presented along with related cost in the security description. The Fund has registration rights for certain restricted securities. Any costs related to such registration are borne by the issuer. The aggregate value of restricted securities (excluding 144A holdings) at September 30, 2018 amounts to $13,769,923 and represents 4.5% of net assets.

(g)

 

The Fund invests in the Institutional Class of the Morgan Stanley Institutional Liquidity Funds - Treasury Securities Portfolio - (the “Liquidity Funds”), an open-end management investment company managed by the Adviser, both directly and as a portion of the securities held as collateral on loaned securities. Advisory fees paid by the Fund are reduced by an amount equal to its pro-rata share of the advisory and administration fees paid by the Fund due to its investment in the Liquidity Funds. For the nine months ended September 30, 2018, advisory fees paid were reduced by $11,447 relating to the Fund’s investment in the Liquidity Funds.

(h)

 

The Fund is permitted to purchase and sell securities (“cross-trade”) from and to other Morgan Stanley Funds as well as other funds and client accounts for which the Adviser or an affiliate of the Adviser serves as investment adviser, pursuant to procedures approved by the Trustees in compliance with Rule 17a-7 under the Act (the “Rule”). Each cross-trade is executed at the current market price in compliance with provisions of the Rule. For the nine months ended September 30, 2018, the Fund did not engage in any cross-trade transactions.

(i)

 

At September 30, 2018, the aggregate cost for federal income tax purposes approximates the aggregate cost for book purposes. The aggregate gross unrealized appreciation is $111,965,398 and the aggregate gross unrealized depreciation is $7,430,054, resulting in net unrealized appreciation of $104,535,344.

 

Call Options Purchased :

 

The Fund had the following call options purchased open at September 30, 2018:

 

Counterparty

 

Description

 

Strike
Price

 

Expiration
Date

 

Number of
Contracts

 

Notional
Amount
(000)

 

Value

 

Premiums
Paid

 

Unrealized
Depreciation

 

Royal Bank of Scotland

 

USD/CNH

 

CHN

7.16

 

Jan-19

 

62,531,078

 

62,531

 

$

188,344

 

$

271,385

 

$

(83,041

)

Royal Bank of Scotland

 

USD/CNH

 

CHN

7.52

 

Nov-18

 

61,605,189

 

61,605

 

1,848

 

255,046

 

(253,198

)

Royal Bank of Scotland

 

USD/CNH

 

CHN

7.78

 

Jul-19

 

61,384,070

 

61,384

 

124,180

 

299,089

 

(174,909

)

 

 

 

 

 

 

 

 

 

 

 

 

$

314,372

 

$

825,520

 

$

(511,148

)

 

Currency Abbreviations:

 

CNH

Chinese Yuan Renminbi Offshore.

USD

United States Dollar.

 


 

Summary of Investments · September 30, 2018 (unaudited)

 

INDUSTRY

 

VALUE

 

PERCENT OF
TOTAL
INVESTMENTS

 

Internet Software & Services

 

$

62,021,273

 

20.0

%

Software

 

58,252,774

 

18.7

 

Internet & Direct Marketing Retail

 

48,959,125

 

15.8

 

Health Care Equipment & Supplies

 

33,494,598

 

10.8

 

Health Care Technology

 

27,447,046

 

8.8

 

Life Sciences Tools & Services

 

23,514,569

 

7.6

 

Road & Rail

 

15,483,505

 

5.0

 

Health Care Providers & Services

 

14,735,985

 

4.7

 

Hotels, Restaurants & Leisure

 

12,823,047

 

4.1

 

Investment Company

 

6,436,156

 

2.1

 

Biotechnology

 

3,385,077

 

1.1

 

Automobiles

 

2,963,219

 

0.9

 

Electronic Equipment, Instruments & Components

 

511,758

 

0.2

 

Pharmaceuticals

 

315,834

 

0.1

 

Purchased Options

 

314,372

 

0.1

 

 

 

$

 310,658,338

+

100.0

%

 


+    Does not reflect the value of securities held as collateral on loaned securities.

 


 

Morgan Stanley Variable Investment Series

 

Notes to Portfolio of Investments · September 30, 2018 (unaudited)

 

In August 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2018-13, Fair Value Measurement (Topic 820) - Disclosures Framework - Changes to Disclosure Requirements of Fair Value Measurement (“ASU 2018-13”) which introduces new fair value disclosure requirements as well as eliminates and modifies certain existing fair value disclosure requirements. ASU 2018-13 would be effective for fiscal years beginning after December 15, 2019 and for interim periods within those fiscal years; however, management has elected to early adopt ASU 2018-13 effective with the current reporting period as permitted by the standard. The impact of the Fund’s adoption was limited to changes in the Fund’s financial statement disclosures regarding fair value, primarily those disclosures related to transfers between levels of the fair value hierarchy and disclosure of the range and weighted average used to develop significant unobservable inputs for Level 3 fair value measurements, when applicable.

 

Valuation of Investments - (1) An equity portfolio security listed or traded on an exchange is valued at its latest reported sales price (or at the exchange official closing price if such exchange reports an official closing price), and if there were no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant exchanges. Listed equity securities not traded on the valuation date with no reported bid and asked prices available on the exchange are valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers. In cases where a security is traded on more than one exchange, the security is valued on the exchange designated as the primary market; (2) all other equity portfolio securities for which over-the-counter (“OTC”) market quotations are readily available are valued at the latest reported sales price (or at the market official closing price if such market reports an official closing price), and if there was no trading in the security on a given day and if there is no official closing price from relevant markets for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available on the relevant markets. An unlisted equity security that does not trade on the valuation date and for which bid and asked prices from the relevant markets are unavailable is valued at the mean between the current bid and asked prices obtained from one or more reputable brokers or dealers; (3) futures are valued at the settlement price on the exchange on which they trade or, if a settlement price is unavailable, at the last sale price on the exchange; (4) listed options are valued at the last reported sales price on the exchange on which they are listed  (or at the exchange official closing price if such exchange reports an official closing price). If an official closing price or last reported sales price is unavailable, the listed option should be fair valued at the mean between its latest bid and ask prices. Unlisted options are valued at the mean between their latest bid and ask prices from a broker/dealer or valued by a pricing service/vendor; (5) OTC swaps may be valued by an outside pricing service approved by the Trust’s Board of Trustees (the “Trustees”) or quotes from a broker or dealer. Swaps cleared on a clearinghouse or exchange may be valued using the closing price provided by the clearinghouse or exchange; (6) quotations of foreign portfolio securities, other assets and liabilities and forward contracts stated in foreign currency are translated into U.S. dollar equivalents at the prevailing market rates prior to the close of the New York Stock Exchange (“NYSE”); (7) certain portfolio securities may be valued by an outside pricing service/vendor approved by the Trustees. The pricing service/vendor may employ a pricing model that takes into account, among other things, bids, yield spreads, and/or other market data and specific security characteristics. Alternatively, if a valuation is not available from an outside pricing service/vendor, and the security trades on an exchange, the security may be valued at its latest reported sale price (or at the exchange official closing price if such exchange reports an official closing price), prior to the time when assets are valued. If there are no sales on a given day and if there is no official exchange closing price for that day, the security is valued at the mean between the last reported bid and asked prices if such bid and asked prices are available in the relevant exchanges; (8) when market quotations are not readily available, including circumstances under which Morgan Stanley Investment Management Inc. (the “Adviser”) or Morgan Stanley Investment Management Limited (the “Sub-Adviser”), a wholly-owned subsidiary of Morgan Stanley, determines that the closing price, last sale price or the mean between the last reported bid and asked prices are not reflective of a security’s market value, portfolio securities are valued at their fair value as determined in good faith under procedures established by and under the general supervision of the Trustees. Occasionally, developments affecting the closing prices of securities and other assets may occur between the times at which valuations of such securities are determined (that is, close of the foreign market on which the securities trade) and the close of business on the

 


 

NYSE. If developments occur during such periods that are expected to materially affect the value of such securities, such valuations may be adjusted to reflect the estimated fair value of such securities as of the close of the NYSE, as determined in good faith by the Trustees or by the Adviser using a pricing service and/or procedures approved by the Trustees; and (9) investments in mutual funds, including the Morgan Stanley Institutional Liquidity Funds, are valued at the net asset value as of the close of each business day.

 

The Trustees have responsibility for determining in good faith the fair value of the investments, and the Trustees may appoint others, such as the Trust’s Adviser or a valuation committee, to assist the Trustees in determining fair value and to make the actual calculations pursuant to the fair valuation methodologies previously approved by the Trustees. Under procedures approved by the Trustees, the Trust’s Adviser has formed a Valuation Committee whose members are approved by the Trustees. The Valuation Committee provides administration and oversight of the Trust’s valuation policies and procedures, which are reviewed at least annually by the Trustees. These procedures allow the Trust to utilize independent pricing services, quotations from securities and financial instrument dealers, and other market sources to determine fair value.

 

Fair Valuation Measurements

 

FASB Accounting Standards CodificationTM (“ASC”) 820, “Fair Value Measurement” (“ASC 820”), defines fair value as the value that the Fund would receive to sell an investment or pay to transfer a liability in a timely transaction with an independent buyer in the principal market, or in the absence of a principal market, the most advantageous market for the investment or liability. ASC 820 establishes a three-tier hierarchy to distinguish between (1) inputs that reflect the assumptions market participants would use in valuing an asset or liability developed based on market data obtained from sources independent of the reporting entity (observable inputs); and (2) inputs that reflect the reporting entity’s own assumptions about the assumptions market participants would use in valuing an asset or liability developed based on the best information available in the circumstances (unobservable inputs) and to establish classification of fair value measurements for disclosure purposes. Various inputs are used in determining the value of the Fund’s investments. The inputs are summarized in the three broad levels listed below:

 

· Level 1 — unadjusted quoted prices in active markets for identical investments

 

· Level 2 — other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, credit risk, etc.)

 

· Level 3 — significant unobservable inputs including the Fund’s own assumptions in determining the fair value of investments.  Factors considered in making this determination may include, but are not limited to, information obtained by contacting the issuer, analysts, or the appropriate stock exchange (for exchange-traded securities), analysis of the issuer’s financial statements or other available documents and, if necessary, available information concerning other securities in similar circumstances

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities and the determination of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each security.

 


 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2018.

 

Investment Type

 

Level 1
Unadjusted
quoted
prices

 

Level 2
Other
significant
observable
inputs

 

Level 3
Significant
unobservable
inputs

 

Total

 

Limited Duration

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Fixed Income Securities

 

 

 

 

 

 

 

 

 

Corporate Bonds

 

$

 

$

14,405,244

 

$

 

$

14,405,244

 

Asset-Backed Securities

 

 

1,644,923

 

 

1,644,923

 

Mortgages - Other

 

 

820,961

 

 

820,961

 

U.S. Treasury Security

 

 

488,773

 

 

488,773

 

Collateralized Mortgage Obligations - Agency Collateral Series

 

 

108,559

 

 

108,559

 

Agency Fixed Rate Mortgages

 

 

67,615

 

 

67,615

 

Total Fixed Income Securities

 

 

17,536,075

 

 

17,536,075

 

Short-Term Investments

 

 

 

 

 

 

 

 

 

U.S. Treasury Security

 

 

50,913

 

 

50,913

 

Investment Company

 

3,866,334

 

 

 

3,866,334

 

Total Short-Term Investments

 

3,866,334

 

50,913

 

 

3,917,247

 

Futures Contract

 

78

 

 

 

78

 

Total Assets

 

3,866,412

 

17,586,988

 

 

21,453,400

 

Liabilities:

 

 

 

 

 

 

 

 

 

Futures Contracts

 

(45,118

)

 

 

(45,118

)

Total

 

$

3,821,294

 

$

17,586,988

 

$

 

$

21,408,282

 

 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2018.

 

Investment Type

 

Level 1
Unadjusted
quoted
prices

 

Level 2
Other
significant
observable
inputs

 

Level 3
Significant
unobservable
inputs

 

Total

 

Income Plus

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Fixed Income Securities

 

 

 

 

 

 

 

 

 

Corporate Bonds

 

$

 

$

80,409,445

 

$

 

$

80,409,445

 

Short-Term Investments

 

 

 

 

 

 

 

 

 

U.S. Treasury Security

 

 

887,484

 

 

887,484

 

Investment Company

 

1,476,978

 

 

 

1,476,978

 

Total Short-Term Investments

 

1,476,978

 

887,484

 

 

2,364,462

 

Futures Contracts

 

152,825

 

 

 

152,825

 

Interest Rate Swap Agreement

 

 

236,670

 

 

236,670

 

Total Assets

 

1,629,803

 

81,533,599

 

 

83,163,402

 

Liabilities:

 

 

 

 

 

 

 

 

 

Futures Contracts

 

(132,250

)

 

 

(132,250

)

Credit Default Swap Agreement

 

 

(20,127

)

 

(20,127

)

Total Liabilities

 

(132,250

)

(20,127

)

 

(152,377

)

Total

 

$

1,497,553

 

$

81,513,472

 

$

 

$

83,011,025

 

 


 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2018.

 

Investment Type

 

Level 1
Unadjusted
quoted
prices

 

Level 2
Other
significant
observable
inputs

 

Level 3
Significant
unobservable
inputs

 

Total

 

European Equity

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Common Stocks

 

 

 

 

 

 

 

 

 

Aerospace & Defense

 

$

843,420

 

$

 

$

 

$

843,420

 

Air Freight & Logistics

 

387,936

 

 

 

387,936

 

Auto Components

 

384,760

 

 

 

384,760

 

Banks

 

2,268,976

 

 

 

2,268,976

 

Capital Markets

 

903,686

 

 

 

903,686

 

Chemicals

 

1,581,696

 

 

 

1,581,696

 

Construction Materials

 

528,468

 

 

 

528,468

 

Diversified Telecommunication Services

 

415,538

 

 

 

415,538

 

Electrical Equipment

 

971,689

 

 

 

971,689

 

Equity Real Estate Investment Trusts (REITs)

 

280,408

 

 

 

280,408

 

Food & Staples Retailing

 

491,177

 

 

 

491,177

 

Food Products

 

1,171,692

 

 

 

1,171,692

 

Health Care Equipment & Supplies

 

533,305

 

 

 

533,305

 

Health Care Providers & Services

 

611,849

 

 

 

611,849

 

Hotels, Restaurants & Leisure

 

1,133,140

 

 

 

1,133,140

 

Household Products

 

751,600

 

 

 

751,600

 

Information Technology Services

 

650,258

 

 

 

650,258

 

Insurance

 

2,012,429

 

 

 

2,012,429

 

Machinery

 

556,003

 

 

 

556,003

 

Media

 

365,638

 

 

 

365,638

 

Oil, Gas & Consumable Fuels

 

1,964,710

 

 

 

1,964,710

 

Personal Products

 

716,003

 

 

 

716,003

 

Pharmaceuticals

 

2,168,579

 

 

 

2,168,579

 

Professional Services

 

470,627

 

 

 

470,627

 

Semiconductors & Semiconductor Equipment

 

642,637

 

 

 

642,637

 

Software

 

959,587

 

 

 

959,587

 

Textiles, Apparel & Luxury Goods

 

469,778

 

 

 

469,778

 

Tobacco

 

1,281,204

 

 

 

1,281,204

 

Total Common Stocks

 

25,516,793

 

 

 

25,516,793

 

Short-Term Investments

 

 

 

 

 

 

 

 

 

Investment Company

 

477,141

 

 

 

477,141

 

Repurchase Agreements

 

 

79,815

 

 

79,815

 

Total Short-Term Investments

 

477,141

 

79,815

 

 

556,956

 

Total Assets

 

$

25,993,934

 

$

79,815

 

$

 

$

26,073,749

 

 


 

The following is a summary of the inputs used to value the Fund’s investments as of September 30, 2018.

 

Investment Type

 

Level 1
Unadjusted
quoted
prices

 

Level 2
Other
significant
observable
inputs

 

Level 3
Significant
unobservable
inputs

 

Total

 

Multi Cap Growth

 

 

 

 

 

 

 

 

 

Assets:

 

 

 

 

 

 

 

 

 

Common Stocks

 

 

 

 

 

 

 

 

 

Automobiles

 

$

2,963,219

 

$

 

$

 

$

2,963,219

 

Biotechnology

 

3,385,077

 

 

 

3,385,077

 

Health Care Equipment & Supplies

 

33,494,598

 

 

 

33,494,598

 

Health Care Providers & Services

 

14,735,985

 

 

 

14,735,985

 

Health Care Technology

 

27,447,046

 

 

 

27,447,046

 

Hotels, Restaurants & Leisure

 

12,823,047

 

 

 

12,823,047

 

Internet & Direct Marketing Retail

 

42,245,092

 

 

 

42,245,092

 

Internet Software & Services

 

62,021,273

 

 

 

62,021,273

 

Life Sciences Tools & Services

 

17,223,923

 

 

 

17,223,923

 

Pharmaceuticals

 

315,834

 

 

 

315,834

 

Road & Rail

 

15,483,505

 

 

 

15,483,505

 

Software

 

57,999,288

 

 

 

57,999,288

 

Total Common Stocks

 

290,137,887

 

 

 

290,137,887

 

Preferred Stocks

 

 

 

 

 

 

 

 

 

Electronic Equipment, Instruments & Components

 

 

 

511,758

 

511,758

 

Internet & Direct Marketing Retail

 

 

 

6,714,033

 

6,714,033

 

Life Sciences Tools & Services

 

 

 

6,290,646

 

6,290,646

 

Software

 

 

 

253,486

 

253,486

 

Total Preferred Stocks

 

 

 

13,769,923

 

13,769,923

 

Call Options Purchased

 

 

314,372

 

 

314,372

 

Short-Term Investments

 

 

 

 

 

 

 

 

 

Investment Company

 

13,010,299

 

 

 

13,010,299

 

Repurchase Agreements

 

 

1,614,702

 

 

1,614,702

 

Total Short-Term Investments

 

13,010,299

 

1,614,702

 

 

14,625,001

 

Total Assets

 

$

303,148,186

 

$

1,929,074

 

$

13,769,923

 

$

318,847,183

 

 

Transfers between investment levels may occur as the markets fluctuate and/or the availability of data used in an investment’s valuation changes.

 

Following is a reconciliation of investments in which significant unobservable inputs (Level 3) were used in determining fair value:

 

 

 

Multi Cap Growth

 

 

 

Preferred Stocks

 

Beginning Balance

 

$

10,306,047

 

Purchases

 

 

Sales

 

 

Amortization of discount

 

 

Transfers in

 

 

Transfers out

 

 

Corporate actions

 

 

Change in unrealized appreciation

 

3,463,876

 

Realized gains

 

 

Ending Balance

 

$

13,769,923

 

 

 

 

 

Net change in unrealized appreciation from investments still held as of September 30, 2018

 

$

 3,463,876

 

 


 

The following table presents additional information about valuation techniques and inputs used for investments that are measured at fair value and categorized within Level 3 as of September 30, 2018. Various valuation techniques were used in the valuation of certain investments and weighted based on the level of significance.

 

Multi Cap Growth

 

Fair Value at
September 30, 2018

 

Valuation Technique

 

Unobservable Input

 

Amount or
Range/Weighted
Average

 

Impact to Valuation
from an increase in
input

Preferred Stocks

 

 

 

 

 

 

 

 

 

 

 

 

$

13,769,923

 

Market Transaction Method

 

Pending and Precedent Transactions

 

$43.95

 

Increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Precedent Transaction

 

$9.57-$27.00 / $11.15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discounted Cash Flow

 

Weighted Average Cost of Capital

 

14.5%-20.0% / 17.5%

 

Decrease

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Perpetual Growth Rate

 

3.0%-4.0% / 3.5%

 

Increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Market Comparable Companies

 

Enterprise Value/Revenue

 

1.4x-12.9x / 6.2x

 

Increase

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discount for Lack of Marketability

 

20.0%

 

Decrease

 


 

Item 2.  Controls and Procedures.

 

(a) The registrant’s principal executive officer and principal financial officer have concluded that the registrant’s disclosure controls and procedures are sufficient to ensure that information required to be disclosed by the registrant in this Form N-Q was recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, based upon such officers’ evaluation of these controls and procedures as of a date within 90 days of the filing date of the report.

 

(b)  There were no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

 

Item 3.  Exhibits.

 

(a) A separate certification for each principal executive officer and principal financial officer of the registrant are attached hereto.

 


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Morgan Stanley Variable Investment Series

 

/s/ John H. Gernon

 

John H. Gernon

 

Principal Executive Officer

 

November 15, 2018

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

/s/ John H. Gernon

 

John H. Gernon

 

Principal Executive Officer

 

November 15, 2018

 

 

 

/s/ Francis Smith

 

Francis Smith

 

Principal Financial Officer

 

November 15, 2018